Francisco Román
González Pachecho
Publicaciones (25) Publicaciones de Francisco Román González Pachecho
2012
2010
-
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: Prevention of angiotensin II-dependent hypertension
Hypertension, Vol. 55, Núm. 1, pp. 90-98
2009
-
Alkalinization potentiates vascular calcium deposition in an uremic milieu
Journal of Nephrology, Vol. 22, Núm. 5, pp. 647-653
-
Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity
Kidney International, Vol. 75, Núm. 2, pp. 227-234
2008
-
Aldosterone increases vascular calcification in "in vitro" studies
Nefrología
-
Angiotensin-converting enzyme 2: Possible role in hypertension and kidney disease
Current Hypertension Reports, Vol. 10, Núm. 1, pp. 70-77
-
Induction of hypoxia-inducible factor 1α gene expression by vascular endothelial growth factor
Journal of Biological Chemistry, Vol. 283, Núm. 17, pp. 11435-11444
2007
-
Mechanisms of endothelial cell protection by blockade of the JAK2 pathway
American Journal of Physiology - Cell Physiology, Vol. 292, Núm. 3
2006
-
Mechanisms of endothelial response to oxidative aggression: Protective role of autologous VEGF and induction of VEGFR2 by H2O2
American Journal of Physiology - Heart and Circulatory Physiology, Vol. 291, Núm. 3
-
Respuesta a la hipoxia. Un mecanismo sistemico basado en el control de la expresion genica
Medicina, Vol. 66, Núm. 2, pp. 155-164
2004
-
Cyclosporin A toxicity, and more: Vascular endothelial growth factor (VEGF) steps forward
Nephrology Dialysis Transplantation
-
Papel del factor de crecimiento endotelial vascular (VEGF) en la protección de las células endoteliales
Nefrología, Vol. 24, Núm. SUPPL.1, pp. 6-7
-
Tumor-induced endothelial cell activation: Role of vascular endothelial growth factor
American Journal of Physiology - Cell Physiology, Vol. 286, Núm. 5 55-5
2003
-
Effect of AT
1
receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3
-
Papel del VEGF en la respuesta celular a la agresión
Nefrologia, Vol. 23, Núm. SUPPL.3, pp. 54-57
2002
-
Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: Role of vascular endothelial growth factor
Circulation Research, Vol. 91, Núm. 3, pp. 202-209
-
Mechanism of vascular smooth muscle cells activation by hydrogen peroxide: Role of phospholipse C gamma
Nephrology Dialysis Transplantation, Vol. 17, Núm. 3, pp. 392-398
-
Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity
Transplantation, Vol. 74, Núm. 11, pp. 1618-1624
2001
-
Structural changes and vascular calcifications in uremia
Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21, Núm. 6, pp. 538-547
2000
-
Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents
Life Sciences, Vol. 67, Núm. 9, pp. 1003-1013